Terms: = Leukemia AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
16 results:
1. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic leukemia.
Oikonomou A; Valsecchi L; Quadri M; Watrin T; Scharov K; Procopio S; Tu JW; Vogt M; Savino AM; Silvestri D; Valsecchi MG; Biondi A; Borkhardt A; Bhatia S; Cazzaniga G; Fazio G; Bardini M; Palmi C
Biochem Pharmacol; 2023 Nov; 217():115809. PubMed ID: 37717691
[TBL] [Abstract] [Full Text] [Related]
2. Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer.
Reale A; Krutzke L; Cadamuro M; Vitiello A; von Einem J; Kochanek S; Palù G; Parolin C; Calistri A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298206
[TBL] [Abstract] [Full Text] [Related]
3. Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
Chen Y; Shao X; Yang H; Ren L; Cui Y; Zhang W; Macip S; Meng X
Eur J Haematol; 2023 Apr; 110(4):435-443. PubMed ID: 36576398
[TBL] [Abstract] [Full Text] [Related]
4. What to use to treat AML: the role of emerging therapies.
Thol F
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):16-23. PubMed ID: 34889359
[TBL] [Abstract] [Full Text] [Related]
5. CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia.
Cafaro A; Giannini MB; Silimbani P; Cangini D; Masini C; Ghelli Luserna Di Rorà A; Simonetti G; Martinelli G; Cerchione C
Minerva Med; 2020 Oct; 111(5):455-466. PubMed ID: 32955826
[TBL] [Abstract] [Full Text] [Related]
6. Treatment of Relapsed Acute Myeloid leukemia.
Thol F; Ganser A
Curr Treat Options Oncol; 2020 Jun; 21(8):66. PubMed ID: 32601974
[TBL] [Abstract] [Full Text] [Related]
7. Blinatumomab for Acute Lymphoblastic leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the ema for Minimal Residual Disease.
Ali S; Moreau A; Melchiorri D; Camarero J; Josephson F; Olimpier O; Bergh J; Karres D; Tzogani K; Gisselbrecht C; Pignatti F
Oncologist; 2020 Apr; 25(4):e709-e715. PubMed ID: 32297447
[TBL] [Abstract] [Full Text] [Related]
8. ema Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX-351) for the Treatment of Adults with Newly Diagnosed, Therapy-Related Acute Myeloid leukemia or Acute Myeloid leukemia with Myelodysplasia-Related Changes.
Tzogani K; Penttilä K; Lapveteläinen T; Hemmings R; Koenig J; Freire J; Márcia S; Cole S; Coppola P; Flores B; Barbachano Y; Roige SD; Pignatti F
Oncologist; 2020 Sep; 25(9):e1414-e1420. PubMed ID: 32282100
[TBL] [Abstract] [Full Text] [Related]
9. Glycan-directed CAR-T cells.
Steentoft C; Migliorini D; King TR; Mandel U; June CH; Posey AD
Glycobiology; 2018 Sep; 28(9):656-669. PubMed ID: 29370379
[TBL] [Abstract] [Full Text] [Related]
10. muc1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells.
Liu S; Yin L; Stroopinsky D; Rajabi H; Puissant A; Stegmaier K; Avigan D; Kharbanda S; Kufe D; Stone R
Blood; 2014 Jan; 123(5):734-42. PubMed ID: 24282218
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.
Hasegawa H; Komoda M; Yamada Y; Yonezawa S; Tsutsumida H; Nagai K; Atogami S; Tsuruda K; Osaka A; Sasaki D; Yanagihara K; Imaizumi Y; Tsukasaki K; Miyazaki Y; Kamihira S
Leuk Lymphoma; 2011 Jun; 52(6):1108-17. PubMed ID: 21599593
[TBL] [Abstract] [Full Text] [Related]
12. Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone.
Lilly AJ; Khanim FL; Hayden RE; Luong QT; Drayson MT; Bunce CM
Cancer Res; 2011 Feb; 71(3):1177-86. PubMed ID: 21169412
[TBL] [Abstract] [Full Text] [Related]
13. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract] [Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (ema) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (ema91 Trial).
Thomas X; Fenaux P; Dombret H; Delair S; Dreyfus F; Tilly H; Vekhoff A; Cony-Makhoul P; Leblond V; Troussard X; Cordonnier C; de Revel T; Simon M; Nicolini F; Stoppa AM; Janvier M; Bordessoule D; Rousselot P; Ffrench M; Marie JP; Archimbaud E
Leukemia; 1999 Aug; 13(8):1214-20. PubMed ID: 10450749
[TBL] [Abstract] [Full Text] [Related]
15. CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic area.
Takeshita M; Ohshima K; Akamatsu M; Ohgami A; Kikuchi M; Suzumiya J; Uike N; Okamura T; Nakayama J
Hum Pathol; 1995 Jun; 26(6):614-9. PubMed ID: 7774890
[TBL] [Abstract] [Full Text] [Related]
16. Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.
Archimbaud E; Thomas X; Leblond V; Michallet M; Fenaux P; Cordonnier C; Dreyfus F; Troussard X; Jaubert J; Travade P
J Clin Oncol; 1995 Jan; 13(1):11-8. PubMed ID: 7799010
[TBL] [Abstract] [Full Text] [Related]
